Literature DB >> 11753638

Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines.

A Mukhopadhyay1, C Bueso-Ramos, D Chatterjee, P Pantazis, B B Aggarwal.   

Abstract

While the role of nuclear transcription factor activator protein-1 (AP-1) in cell proliferation, and of nuclear factor-kappaB (NF-kappaB) in the suppression of apoptosis are known, their role in survival of prostate cancer cells is not well understood. We investigated the role of NF-kappaB and AP-1 in the survival of human androgen-independent (DU145) and -dependent (LNCaP) prostate cancer cell lines. Our results show that the faster rate of proliferation of DU145 cells when compared to LNCaP cells correlated with the constitutive expression of activated NF-kappaB and AP-1 in DU-145 cells. The lack of constitutive expression of NF-kappaB and AP-1 in LNCaP cells also correlated with their sensitivity to the antiproliferative effects of tumor necrosis factor (TNF). TNF induced NF-kappaB activation but not AP-1 activation in LNCaP cells. In DU145 cells both c-Fos and c-Jun were expressed and treatment with TNF activated c-Jun NH2-terminal kinase (JNK), needed for AP-1 activation. In LNCaP cells, however, only low levels of c-Jun was expressed and treatment with TNF minimally activated JNK. Treatment of cells with curcumin, a chemopreventive agent, suppressed both constitutive (DU145) and inducible (LNCaP) NF-kappaB activation, and potentiated TNF-induced apoptosis. Curcumin alone induced apoptosis in both cell types, which correlated with the downregulation of the expression of Bcl-2 and Bcl-xL and the activation of procaspase-3 and procaspase-8. Overall, our results suggest that NF-kappaB and AP-1 may play a role in the survival of prostate cancer cells, and curcumin abrogates their survival mechanisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11753638     DOI: 10.1038/sj.onc.1204997

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  102 in total

Review 1.  Cancer cell signaling pathways targeted by spice-derived nutraceuticals.

Authors:  Bokyung Sung; Sahdeo Prasad; Vivek R Yadav; Bharat B Aggarwal
Journal:  Nutr Cancer       Date:  2011-12-09       Impact factor: 2.900

2.  Epigenetic changes induced by curcumin and other natural compounds.

Authors:  Simone Reuter; Subash C Gupta; Byoungduck Park; Ajay Goel; Bharat B Aggarwal
Journal:  Genes Nutr       Date:  2011-04-24       Impact factor: 5.523

3.  Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay.

Authors:  Arno Pol; Mieke Bergers; Joost Schalkwijk
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jan-Feb       Impact factor: 2.416

4.  Growth-inhibitory effects of curcumin on ovary cancer cells and its mechanisms.

Authors:  Liduan Zheng; Qiangsong Tong; Cuihuan Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

Review 5.  Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Subhash Padhye
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

6.  Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer.

Authors:  Sharanjot Saini; Sumit Arora; Shahana Majid; Varahram Shahryari; Yi Chen; Guoren Deng; Soichiro Yamamura; Koji Ueno; Rajvir Dahiya
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-11

7.  Active curcumin nanoparticles formed from a volatile microemulsion template.

Authors:  K Margulis; S Srinivasan; M J Ware; H D Summers; B Godin; S Magdassi
Journal:  J Mater Chem B       Date:  2014       Impact factor: 6.331

Review 8.  Cellular signaling perturbation by natural products.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong
Journal:  Cell Signal       Date:  2009-03-16       Impact factor: 4.315

9.  Curcumin for the Treatment of Prostate Diseases: A Systematic Review of Controlled Clinical Trials.

Authors:  Mohammad Bagherniya; Gholamreza Askari; Babak Alikiaii; Saeed Abbasi; Davood Soleimani; Thozhukat Sathyapalan; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Effects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-κB activity in PC-3 human prostate cancer cells.

Authors:  Xingchuan Wei; Zhi-Yun DU; Xiao-Xing Cui; Michael Verano; Rong Qing Mo; Zhi Kai Tang; Allan H Conney; Xi Zheng; Kun Zhang
Journal:  Oncol Lett       Date:  2012-05-10       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.